Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib.
Cancer Research
Crona, Daniel J DJ; Skol, Andrew D AD; Leppänen, Veli-Matti VM; Glubb, Dylan M DM; Etheridge, Amy S AS; Hilliard, Eleanor E; Peña, Carol E CE; Peterson, Yuri K YK; Klauber-DeMore, Nancy N; Alitalo, Kari K KK; Innocenti, Federico F